Format
Sort by
Items per page

Send to

Choose Destination

Best matches for TNM staging uveal melanoma:

Uveal melanoma: estimating prognosis. Kaliki S et al. Indian J Ophthalmol. (2015)

Uveal Melanoma UK National Guidelines. Nathan P et al. Eur J Cancer. (2015)

Biology of advanced uveal melanoma and next steps for clinical therapeutics. Luke JJ et al. Pigment Cell Melanoma Res. (2015)

Search results

Items: 1 to 20 of 114

1.

Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.

Jang BS, Chang JH, Oh S, Lim YJ, Kim IH.

Strahlenther Onkol. 2017 Nov;193(11):931-942. doi: 10.1007/s00066-017-1203-0. Epub 2017 Sep 6.

PMID:
28879443
2.

Comparison of Alternative Tumor Size Classifications for Posterior Uveal Melanomas.

Skinner CC, Augsburger JJ, Augsburger BD, Correa ZM.

Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3335-3342. doi: 10.1167/iovs.16-20465.

PMID:
28672400
3.

Uveal Melanoma Treatment and Prognostication.

Dogrusöz M, Jager MJ, Damato B.

Asia Pac J Ophthalmol (Phila). 2017 Mar-Apr;6(2):186-196. doi: 10.22608/APO.201734. Review. Erratum in: Asia Pac J Ophthalmol (Phila). 2017 May-Jun;6(3):305.

4.

Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.

Park SJ, Oh CM, Yeon B, Cho H, Park KH.

Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1909-1915. doi: 10.1167/iovs.16-20077.

PMID:
28362882
5.

The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status.

Dogrusöz M, Bagger M, van Duinen SG, Kroes WG, Ruivenkamp CA, Böhringer S, Andersen KK, Luyten GP, Kiilgaard JF, Jager MJ.

Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):833-842. doi: 10.1167/iovs.16-20212.

PMID:
28159971
6.

Cytogenetic Abnormalities in Uveal Melanoma Based on Tumor Features and Size in 1059 Patients: The 2016 W. Richard Green Lecture.

Shields CL, Say EAT, Hasanreisoglu M, Saktanasate J, Lawson BM, Landy JE, Badami AU, Sivalingam MD, Mashayekhi A, Shields JA, Ganguly A.

Ophthalmology. 2017 May;124(5):609-618. doi: 10.1016/j.ophtha.2016.12.026. Epub 2017 Jan 31.

PMID:
28159380
7.

Prognostic Implications of the Largest Basal Tumor Diameter vs the TNM Staging System in Association With the Gene Expression Profile for Uveal Melanoma.

Kivelä TT, Finger PT.

JAMA Ophthalmol. 2017 Jan 5. doi: 10.1001/jamaophthalmol.2016.5102. [Epub ahead of print] No abstract available.

PMID:
28056132
8.

Prognostic Implications of the Largest Basal Tumor Diameter vs the TNM Staging System in Association With the Gene Expression Profile for Uveal Melanoma-Reply.

Harbour JW.

JAMA Ophthalmol. 2017 Jan 5. doi: 10.1001/jamaophthalmol.2016.5109. [Epub ahead of print] No abstract available.

PMID:
28056125
9.

Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.

King B, Morales-Tirado VM, Wynn HG, Gao BT, Ballo MT, Wilson MW.

Am J Ophthalmol. 2017 Apr;176:40-45. doi: 10.1016/j.ajo.2016.12.022. Epub 2016 Dec 31.

PMID:
28048976
10.

Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands.

van der Kooij MK, Joosse A, Speetjens FM, Hospers GA, Bisschop C, de Groot JW, Koornstra R, Blank CU, Kapiteijn E.

Acta Oncol. 2017 Jan;56(1):101-103. doi: 10.1080/0284186X.2016.1260773. Epub 2016 Dec 2. No abstract available.

PMID:
27911126
11.

External Validation of the Liverpool Uveal Melanoma Prognosticator Online.

DeParis SW, Taktak A, Eleuteri A, Enanoria W, Heimann H, Coupland SE, Damato B.

Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6116-6122. doi: 10.1167/iovs.16-19654.

PMID:
27835710
12.

Histopathologic Analysis of Transvitreal Fine Needle Aspiration Biopsy Needle Tracts for Uveal Melanoma.

Kim RS, Chevez-Barrios P, Bretana ME, Wong TP, Teh BS, Schefler AC.

Am J Ophthalmol. 2017 Feb;174:9-16. doi: 10.1016/j.ajo.2016.10.019. Epub 2016 Nov 4.

PMID:
27818205
13.

Germline BAP1 alterations in familial uveal melanoma.

Rai K, Pilarski R, Boru G, Rehman M, Saqr AH, Massengill JB, Singh A, Marino MJ, Davidorf FH, Cebulla CM, H Abdel-Rahman M.

Genes Chromosomes Cancer. 2017 Feb;56(2):168-174. doi: 10.1002/gcc.22424. Epub 2016 Oct 26.

PMID:
27718540
14.

Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies.

Algazi AP, Tsai KK, Shoushtari AN, Munhoz RR, Eroglu Z, Piulats JM, Ott PA, Johnson DB, Hwang J, Daud AI, Sosman JA, Carvajal RD, Chmielowski B, Postow MA, Weber JS, Sullivan RJ.

Cancer. 2016 Nov 15;122(21):3344-3353. doi: 10.1002/cncr.30258. Epub 2016 Aug 17.

15.

Management and Outcome of Uveal Melanoma in a Single Tertiary Cancer Center in Jordan.

Zewar A, Nawaiseh I, Jaradat I, Khzouz J, Alrawashdeh K, Abdeen G, Mehyar M, Khurma S, Yousef YA.

Turk Patoloji Derg. 2016;32(3):186-92. doi: 10.5146/tjpath.2015.01357.

16.

Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group.

Kivelä TT, Piperno-Neumann S, Desjardins L, Schmittel A, Bechrakis N, Midena E, Leyvraz S, Zografos L, Grange JD, Ract-Madoux G, Marshall E, Damato B, Eskelin S.

Am J Ophthalmol. 2016 Aug;168:217-226. doi: 10.1016/j.ajo.2016.06.002. Epub 2016 Jun 11.

PMID:
27296487
17.

Uveal melanoma: From diagnosis to treatment and the science in between.

Chattopadhyay C, Kim DW, Gombos DS, Oba J, Qin Y, Williams MD, Esmaeli B, Grimm EA, Wargo JA, Woodman SE, Patel SP.

Cancer. 2016 Aug 1;122(15):2299-312. doi: 10.1002/cncr.29727. Epub 2016 Mar 15. Review.

18.

Management of uveal tract melanoma: A comprehensive review.

Kapoor A, Beniwal V, Beniwal S, Mathur H, Kumar HS.

J Egypt Natl Canc Inst. 2016 Jun;28(2):65-72. doi: 10.1016/j.jnci.2016.02.003. Epub 2016 Mar 11. Review.

19.

Brachytherapy vs. external beam radiotherapy for choroidal melanoma: Survival and patterns-of-care analyses.

Abrams MJ, Gagne NL, Melhus CS, Mignano JE.

Brachytherapy. 2016 Mar-Apr;15(2):216-23. doi: 10.1016/j.brachy.2015.12.001. Epub 2016 Feb 1.

PMID:
26846381
20.

Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.

Hu K, Babapoor-Farrokhran S, Rodrigues M, Deshpande M, Puchner B, Kashiwabuchi F, Hassan SJ, Asnaghi L, Handa JT, Merbs S, Eberhart CG, Semenza GL, Montaner S, Sodhi A.

Oncotarget. 2016 Feb 16;7(7):7816-28. doi: 10.18632/oncotarget.6868.

Supplemental Content

Loading ...
Support Center